Evidence map›Paper›PMID 40442799›Full record

ArticleHarm reduction journal2025

Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa.

Nkeka Peter Tseole, Julian David Pillay

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nkeka Peter TseoleFaculty of Health Sciences, Durban University of Technology, Durban, South Africa. nkekathabiso@gmail.com.
Julian David PillayFaculty of Health Sciences, Durban University of Technology, Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance abuse is a significant public health concern globally, exposing individuals to substantial health risks and mortality. Despite the effectiveness of harm reduction interventions, they remain limited and inadequately accessible in South Africa, where substance use prevalence is increasing. This study explores the perspectives of community volunteers and student interns on harm reduction and its interventions using Bellhaven Harm Reduction Centre as a case study.

methodsThis qualitative study employed a cross-sectional design, utilising thematic analysis to examine the views of 15 participants on harm reduction programs and their experiences within the harm reduction centre context.

resultsThe findings indicate that harm reduction interventions have a positive impact on all stakeholders, fostering transformative attitudes toward substance use and promoting empathy and understanding. Our findings highlight four major themes: the client-focused nature of harm reduction interventions, their ability to reduce stigma and discrimination against marginalised populations, their capacity-building nature, and ability to reduce substance abuse-related harm.

conclusionThis study highlights the value of harm reduction programs in addressing substance use challenges, emphasizing client-centered care, capacity building, and stigma reduction. The findings provide a valuable model for resource-constrained environments, informing policy and practice to improve health outcomes among vulnerable populations.

Indexed as

Harm ReductionInternship and ResidencyStudentsSubstance-Related DisordersVolunteersAdultCross-Sectional StudiesFemaleHumansMaleQualitative ResearchSocial StigmaSouth AfricaYoung AdultClient-centered careCommunity engagementHarm reductionSouth AfricaStigma reductionSubstance use

Identifiers

PMID40442799
PMCPMC12121275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.